EFFECT OF RAPAMYCIN ON RAT AORTIC RING VASOMOTION

被引:20
作者
CORBIN, F
BLAISE, GA
PARENT, M
CHEN, HF
DALOZE, PM
机构
[1] UNIV MONTREAL,NOTRE DAME HOSP,DEPT ANAESTHESIOL,MONTREAL H3C 3J7,PQ,CANADA
[2] UNIV MONTREAL,NOTRE DAME HOSP,DEPT SURG,MONTREAL H3C 3J7,PQ,CANADA
关键词
IMMUNOSUPPRESSIVE AGENTS; RAPAMYCIN; ENDOTHELIUM; VASCULAR; AORTA; RAT;
D O I
10.1097/00005344-199424050-00017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rapamycin (PAPA) is an antifungal antibiotic with interesting new immunosuppressive properties. We evaluated RAPA's effects in vitro on basal and stimulated tension of isolated intact or denuded rat aortic rings. Rings were prepared in an organ chamber and contracted with 40 mM KCl (reference 100%). Some rings were treated with either RAPA's polysorbate/polyethylene glycol-based (PEG) vehicle (0.8% vol/vol) or with different concentrations of RAPA (10, 100, and 1,000 ng/ml) diluted in PEG; untreated rings were used as controls. Variation in tension with time (2 h) and the dose-response to thromboxane A(2) analogue (U46619) and phenylephrine (PE) were measured in controls and treated rings. PEG potentiated the increase in basal tension in rings with endothelium after 2-h treatment (44.66 +/- 3.59 vs. 14.82 +/- 2.43% for controls, p < 0.05, n = 10). RAPA antagonized the contraction induced by its own vehicle dose dependently. At 1,000 ng/ml, PAPA caused relaxation of intact rings below the control level (4.29 +/- 2.20 vs. 14.82 +/- 2.43%, p < 0.05, n = 10), but not in rings without endothelium. RAPA did not modify the response to PE or U46619 in rings with endothelium. PAPA relaxed the vessels by an endothelium-dependent mechanism, and this effect can be modulated by its vasoconstrictive PEG vehicle.
引用
收藏
页码:813 / 817
页数:5
相关论文
共 50 条
  • [1] ABRAHAM JS, 1991, SURGERY, V110, P343
  • [2] AKSELBAND Y, 1991, TRANSPLANT P, V23, P2833
  • [3] SIDE-EFFECTS OF CYCLOSPORINE-A TREATMENT IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    BERG, KJ
    FORRE, O
    BJERKHOEL, F
    AMUNDSEN, E
    DJOSELAND, O
    RUGSTAD, HE
    WESTRE, B
    [J]. KIDNEY INTERNATIONAL, 1986, 29 (06) : 1180 - 1187
  • [4] PREVENTION OF CYCLOSPORINE-A-INDUCED VASCULAR TOXICITY BY PENTOXIFYLLINE
    BERKENBOOM, G
    UNGER, P
    GOLDMAN, M
    FANG, ZY
    FONTAINE, J
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 (05) : 761 - 768
  • [5] MECHANISM OF HALOTHANE ATTENUATION OF ISOMETRIC TENSION INDUCED BY SEROTONIN IN ISOLATED CANINE CORONARY-ARTERY RINGS
    BLAISE, G
    DUMONT, L
    BULURAN, J
    OMRI, A
    SILL, C
    DELEAN, A
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 (03) : 445 - 450
  • [6] Blaise G A, 1994, J Cardiothorac Vasc Anesth, V8, P175, DOI 10.1016/1053-0770(94)90058-2
  • [7] CYCLOSPORINE A INHIBITS ENDOTHELIUM-DEPENDENT VASODILATATION AND VASCULAR PROSTACYCLIN PRODUCTION
    BOSSALLER, C
    FORSTERMANN, U
    HERTEL, R
    OLBRICHT, C
    RESCHKE, V
    FLECK, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 165 (01) : 165 - 169
  • [8] INHIBITION OF PROSTACYCLIN FORMATION BY CYCLOSPORINE IS NOT DUE TO REDUCED AVAILABILITY OF ARACHIDONIC-ACID IN MEMBRANE PHOSPHOLIPIDS OF CULTURED HUMAN ENDOTHELIAL-CELLS
    BROWN, Z
    NEILD, GH
    LEWIS, GP
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 39 (06) : 1136 - 1138
  • [9] CALNE RY, 1989, LANCET, V2, P227
  • [10] DOSE-DEPENDENT EFFECT OF CYCLOSPORINE ON RENAL ARTERIAL RESISTANCE IN DOGS
    CARRIER, M
    TRONC, F
    STEWART, D
    PELLETIER, LC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (06): : H1791 - H1796